Microsporidiosis primary prevention

Acute viral nasopharyngitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating acute viral nasopharyngitis from other diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X ray
CT
MRI
Ultrasound
Other imaging findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Microsporidiosis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Microsporidiosis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
National Guidelines Clearinghouse
NICE Guidance
FDA on Microsporidiosis primary prevention
CDC on Microsporidiosis primary prevention
Microsporidiosis primary prevention in the news
Blogs onMicrosporidiosis primary prevention
Directions to Hospitals Treating Osteoporosis
Risk calculators and risk factors for Microsporidiosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Effective measures for the primary prevention of microsporidiosis include HAART, avoiding contact with poultry and avoiding swimming pools.

Primary prevention

In immunocompromised patients, HAART and maintaining CD4 count above 100 cells/mcL is the most effective primary preventive measure to prevent the development of the disease. In an Australian study, mortality due to microsporidiosis decreased in patients receiving HAART.

Other preventive measures include

• Avoiding contact with poultry
• Avoiding swimming pools